BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Art Pappas will participate on a panel called "Venture Capital and Private Equity - How Do You Look for the Next Big Investment" at the Drug Delivery Partnerships conference in Las Vegas, NV
News | 01. 22. 2009
